Global Patent Index - EP 1259812 A2

EP 1259812 A2 2002-11-27 - BREAST, GASTRIC AND PROSTATE CANCER ASSOCIATED ANTIGENS AND USES THEREFOR

Title (en)

BREAST, GASTRIC AND PROSTATE CANCER ASSOCIATED ANTIGENS AND USES THEREFOR

Title (de)

MIT BRUST-, MAGEN- UND PROSTATAKREBS IN VERBINDUNG STEHENDE ANTIGENE UND DEREN VERWENDUNG

Title (fr)

ANTIGENES ASSOCIES AU CANCER DU SEIN, DE LA PROSTATE ET DE L'ESTOMAC ET LEUR UTILISATION

Publication

EP 1259812 A2 (EN)

Application

EP 00932804 A

Priority

  • US 0014749 W
  • US 13652699 P
  • US 15345499 P

Abstract (en)

[origin: WO0073801A2] Cancer associated antigens have been identified by autologous antibody screening of libraries of nucleic acids expressed in breast, gastric and prostate cancer cells using antisera from cancer patients. The invention relates to nucleic acids and encoded polypeptides which are cancer associated antigens expressed in patients afflicted with cancer. The invention provides, <i>inter alia</i>, isolated nucleic acid molecules, expression vectors containing those molecules and host cells transfected with those molecules. The invention also provides isolated proteins and peptides, antibodies to those proteins and peptides and cytotoxic T lymphocytes which recognize the proteins and peptides. Fragments of the foregoing including functional fragments and variants also are provided. Kits containing the foregoing molecules additionally are provided. The molecules provided by the invention can be used in the diagnosis, monitoring, research, or treatment of conditions characterized by the expression of one or more cancer associated antigens.

IPC 1-7 (main, further and additional classification)

G01N 33/574; A61K 35/14; A61K 39/00; A61K 39/395; A61K 48/00; C07K 7/04; C07K 14/47; C07K 16/18; C12N 5/10; C12N 15/63; C12Q 1/68

IPC 8 full level (invention and additional information)

G01N 33/50 (2006.01); A61K 31/7088 (2006.01); A61K 35/12 (2006.01); A61K 39/00 (2006.01); A61K 39/39 (2006.01); A61K 39/395 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); C07K 19/00 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12P 21/08 (2006.01); C12Q 1/02 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/53 (2006.01); G01N 33/566 (2006.01); G01N 33/574 (2006.01); A61K 38/00 (2006.01)

CPC (invention and additional information)

A61K 39/0011 (2013.01); C07K 14/4748 (2013.01); G01N 33/57484 (2013.01); A61K 38/00 (2013.01); A61K 2039/5152 (2013.01); A61K 2039/5156 (2013.01); A61K 2039/53 (2013.01)

Citation (search report)

See references of WO 0073801A3

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 0073801 A2 20001207; WO 0073801 A3 20020912; AU 5047800 A 20001218; EP 1259812 A2 20021127; JP 2003518364 A 20030610

INPADOC legal status


2005-06-15 [18W] WITHDRAWN

- Effective date: 20050421

2002-11-27 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20011221

2002-11-27 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A2

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE